Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0001193125-25-314740

Director sold 93,445 shares at an average $14.65 ($1,369,324)

  • Director acquired 87,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

HENRY CHRISTIAN O · Director

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Sale : show line 1 in the form 10b5-1 −6,445 $12.75 $82,174 12,700 D
2025-12-08 Exercise or conversion : show line 2 in the form 10b5-1 +42,000 $5.97 $250,740 54,700 D
2025-12-08 Sale : show line 3 in the form 10b5-1 −42,000 $12.75 $535,500 12,700 D
2025-12-08 Exercise or conversion : show line 4 in the form 10b5-1 +15,000 $3.50 $52,500 27,700 D
2025-12-08 Sale : show line 5 in the form 10b5-1 −15,000 $14.07 $211,050 12,700 D
2025-12-08 Exercise or conversion : show line 6 in the form 10b5-1 +30,000 $4.59 $137,550 42,700 D
2025-12-08 Sale : show line 7 in the form 10b5-1 −30,000 $18.02 $540,600 12,700 D
Open-market sales · 93,445 sh · avg $14.65 · $1,369,324

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-12-08 Exercise or conversion : show line 8 in the form 10b5-1 Share Option (right to buy) −42,000 0 D
2025-12-08 Exercise or conversion : show line 9 in the form 10b5-1 Share Option (right to buy) −15,000 6,000 D
2025-12-08 Exercise or conversion : show line 10 in the form 10b5-1 Share Option (right to buy) −30,000 15,000 D
Loading xslF345X05/ownership.xml…